載入...
Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox–Gastaut syndrome
Clobazam is the newest medication approved by the US Food and Drug Administration (FDA) for the treatment of Lennox–Gastaut syndrome (LGS) in patients at least 2 years of age, although the medication has been available in countries around the world to treat epilepsy and anxiety disorders for many ye...
Na minha lista:
| 發表在: | Ther Clin Risk Manag |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4467745/ https://ncbi.nlm.nih.gov/pubmed/26089675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S55930 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|